Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Solid Carcinoma 1Pancreatic Ductal Adenocarcinoma 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Myelodysplastic Syndromes 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1Diarrhea 1Colitis 1Cachexia 1Breast Neoplasms 1

Interventions

Bevacizumab 37Paclitaxel 33Carboplatin 25pembrolizumab 23Specimen Handling 21olaparib 19Magnetic Resonance Spectroscopy 19Gemcitabine 18liposomal doxorubicin 16Cyclophosphamide 16fludarabine 12Topotecan 12Biopsy 12niraparib 11Cisplatin 10Fulvestrant 9Taxes 8Nivolumab 8Immunoglobulin G 8Disulfides 8Doxorubicin 7palbociclib 6aldesleukin 6Surveys and Questionnaires 6Oxaliplatin 5Letrozole 5Fluorouracil 5trastuzumab deruxtecan 4oregovomab 4mirvetuximab soravtansine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Fecal Microbiota Transplantation × 90 days × Clear all
NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡